Integrative Program for Biological and Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Department of Biology, University of Kentucky, Lexington, KY, USA.
BMC Biol. 2024 Apr 25;22(1):94. doi: 10.1186/s12915-024-01888-z.
Spinal muscular atrophy (SMA) is a devastating neuromuscular disease caused by hypomorphic loss of function in the survival motor neuron (SMN) protein. SMA presents across a broad spectrum of disease severity. Unfortunately, genetic models of intermediate SMA have been difficult to generate in vertebrates and are thus unable to address key aspects of disease etiology. To address these issues, we developed a Drosophila model system that recapitulates the full range of SMA severity, allowing studies of pre-onset biology as well as late-stage disease processes.
Here, we carried out transcriptomic and proteomic profiling of mild and intermediate Drosophila models of SMA to elucidate molecules and pathways that contribute to the disease. Using this approach, we elaborated a role for the SMN complex in the regulation of innate immune signaling. We find that mutation or tissue-specific depletion of SMN induces hyperactivation of the immune deficiency (IMD) and Toll pathways, leading to overexpression of antimicrobial peptides (AMPs) and ectopic formation of melanotic masses in the absence of an external challenge. Furthermore, the knockdown of downstream targets of these signaling pathways reduced melanotic mass formation caused by SMN loss. Importantly, we identify SMN as a negative regulator of a ubiquitylation complex that includes Traf6, Bendless, and Diap2 and plays a pivotal role in several signaling networks.
In alignment with recent research on other neurodegenerative diseases, these findings suggest that hyperactivation of innate immunity contributes to SMA pathology. This work not only provides compelling evidence that hyperactive innate immune signaling is a primary effect of SMN depletion, but it also suggests that the SMN complex plays a regulatory role in this process in vivo. In summary, immune dysfunction in SMA is a consequence of reduced SMN levels and is driven by cellular and molecular mechanisms that are conserved between insects and mammals.
脊髓性肌萎缩症(SMA)是一种由运动神经元存活(SMN)蛋白功能低下引起的毁灭性神经肌肉疾病。SMA 的表现存在广泛的疾病严重程度差异。不幸的是,中间型 SMA 的遗传模型在脊椎动物中很难产生,因此无法解决疾病病因的关键方面。为了解决这些问题,我们开发了一个果蝇模型系统,该系统再现了 SMA 的全范围严重程度,允许研究发病前的生物学以及晚期疾病过程。
在这里,我们对轻度和中度 SMA 的果蝇模型进行了转录组和蛋白质组分析,以阐明导致疾病的分子和途径。通过这种方法,我们阐述了 SMN 复合物在调节固有免疫信号中的作用。我们发现,SMN 的突变或组织特异性缺失会诱导免疫缺陷(IMD)和 Toll 途径的过度激活,导致抗菌肽(AMPs)的过表达和黑色素团在没有外部挑战的情况下异位形成。此外,这些信号通路下游靶标的敲低减少了由 SMN 缺失引起的黑色素团形成。重要的是,我们确定 SMN 是一个包括 Traf6、Bendless 和 Diap2 的泛素化复合物的负调节剂,该复合物在几个信号网络中发挥关键作用。
与最近关于其他神经退行性疾病的研究一致,这些发现表明固有免疫的过度激活导致 SMA 病理学。这项工作不仅提供了令人信服的证据,证明 SMN 耗竭导致固有免疫过度激活,而且表明 SMN 复合物在体内的这个过程中发挥调节作用。总之,SMA 中的免疫功能障碍是 SMN 水平降低的结果,是由昆虫和哺乳动物之间保守的细胞和分子机制驱动的。